-
H.C. Wainwright: Acadia Is More Than A One-Trick Pony
Wednesday, November 8, 2017 - 1:26pm | 309Read More...ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) on Tuesday reported second-quarter earnings, which consisted of a better than expected loss per share (53 cents versus expectations for 62 cents)and a revenue beat ($35.6 million versus expectations for $32.03 million). Sales of the company's only...
-
Acadia's FDA Breakthrough Designation For Pimavanserin Draws Mixed Response
Thursday, October 5, 2017 - 2:20pm | 663Read More...ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stock initially jumped above $41 per share on Thursday after the FDA granted Breakthrough Designation to the company’s dementia-related psychosis drug candidate Pimavanserin. However, the stock quickly reversed direction as the market digested the...
-
ACADIA Meets Primary Endpoint Alzheimer's Disease Exploratory Study; Stock Rallys
Tuesday, December 20, 2016 - 11:27am | 279Read More...Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) gained more than 15 percent early Tuesday morning after the company announced positive top-line results from a Phase II study (-019 Study) of its therapy to treat Alzheimer's Disease called pimavanserin. Acadia's therapy has a different...
-
Acadia Continues Huge Rise Following FDA Panel Vote
Wednesday, March 30, 2016 - 7:52am | 177Read More...Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) were trading higher by more than 22 percent early Wednesday morning. A U.S. Food and Drug Administration panel voted 12-2 on Tuesday that Acadia's drug pimavanserin, a treatment for psychosis associated with Parkinson's disease,...
-
Acadia Surges 22% After FDA Releases Briefing Documents
Monday, March 28, 2016 - 1:27pm | 348Read More...Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company that focuses on the development and commercialization of medicines for the treatment of neurological and central nervous system disorders, surged higher by more than 20 percent on Monday. According to Fierce...
-
Dream Stocks: April's Strongest Performers (SIFY, AMRN, REDF, KUTV, ACAD)
Friday, April 29, 2011 - 11:06am | 318Read More...The following five stocks have made shareholders extremely happy recently, as they are the top percentage gainers in the market for the month of April. All of the companies reside in the NASDAQ, as pharmaceutical and internet stocks have garnered significant attention from investors and money...
